Media Summary: Matteo Carlino, FRACP, PhD, University of Sydney and Westmead Hospital, Sydney, Australia, provides an overview of 5-year ... Pavlos Msaouel, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, outlines the results of a meta- Tiziano Barbui, MD, Bergamo Hospital Research Foundation, Bergamo, Italy, shares some insights into the impact of ruxolitinib on ...

Long Term Survival Data From - Detailed Analysis & Overview

Matteo Carlino, FRACP, PhD, University of Sydney and Westmead Hospital, Sydney, Australia, provides an overview of 5-year ... Pavlos Msaouel, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, outlines the results of a meta- Tiziano Barbui, MD, Bergamo Hospital Research Foundation, Bergamo, Italy, shares some insights into the impact of ruxolitinib on ... Vinay Prasad, MD MPH; Physician & Professor Hematologist/ Oncologist Professor of Epidemiology, Biostatistics and Medicine ... Saby George, MD, FACP, Roswell Park Comprehensive Cancer Center, continues with a discussion on the Sabrina Paganoni, MD, PhD, Massachusetts General Hospital, Harvard Medical School, Boston, MA, shares the results of a ...

Today I'm going to talk about some modeling of In this presentation, Maria Teresa Voso, MD, of Tor Vergata University, Rome, Italy, discusses a study using See all my videos at 0:00 Intro 0:37 CENSORING 2:46 Example - Right censoring 5:18 ...

Photo Gallery

Long term survival data from the Phase III Keynote-054 trial
Survival Analysis [Simply Explained]
Long-Term Survival and Adverse Effects With Ruxolitinib
Long-term survival outcomes for mRCC after cytoreductive neprectomy
The impact of ruxolitinib on the long-term survival of patients with MF
Mini Lecture: Survival Analysis
How to read Kaplan-Meier plots
CheckMate 214: Long-Term Survival Implications, Treatment Ramifications for Favorable-Risk Patients
AMX0035 in ALS: long-term survival analysis of the CENTAUR trial
Webinar "Modeling of Long-Term Survival Outcomes in R"
Analysis of long-term survival in a large APL patient cohort: a Harmony Alliance study
The Statistics of Life and Death | Survival Analysis
View Detailed Profile
Long term survival data from the Phase III Keynote-054 trial

Long term survival data from the Phase III Keynote-054 trial

Matteo Carlino, FRACP, PhD, University of Sydney and Westmead Hospital, Sydney, Australia, provides an overview of 5-year ...

Survival Analysis [Simply Explained]

Survival Analysis [Simply Explained]

This video is all about

Long-Term Survival and Adverse Effects With Ruxolitinib

Long-Term Survival and Adverse Effects With Ruxolitinib

Experts discuss the

Long-term survival outcomes for mRCC after cytoreductive neprectomy

Long-term survival outcomes for mRCC after cytoreductive neprectomy

Pavlos Msaouel, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, outlines the results of a meta-

The impact of ruxolitinib on the long-term survival of patients with MF

The impact of ruxolitinib on the long-term survival of patients with MF

Tiziano Barbui, MD, Bergamo Hospital Research Foundation, Bergamo, Italy, shares some insights into the impact of ruxolitinib on ...

Mini Lecture: Survival Analysis

Mini Lecture: Survival Analysis

A brief introduction to the modelling of

How to read Kaplan-Meier plots

How to read Kaplan-Meier plots

Vinay Prasad, MD MPH; Physician & Professor Hematologist/ Oncologist Professor of Epidemiology, Biostatistics and Medicine ...

CheckMate 214: Long-Term Survival Implications, Treatment Ramifications for Favorable-Risk Patients

CheckMate 214: Long-Term Survival Implications, Treatment Ramifications for Favorable-Risk Patients

Saby George, MD, FACP, Roswell Park Comprehensive Cancer Center, continues with a discussion on the

AMX0035 in ALS: long-term survival analysis of the CENTAUR trial

AMX0035 in ALS: long-term survival analysis of the CENTAUR trial

Sabrina Paganoni, MD, PhD, Massachusetts General Hospital, Harvard Medical School, Boston, MA, shares the results of a ...

Webinar "Modeling of Long-Term Survival Outcomes in R"

Webinar "Modeling of Long-Term Survival Outcomes in R"

Today I'm going to talk about some modeling of

Analysis of long-term survival in a large APL patient cohort: a Harmony Alliance study

Analysis of long-term survival in a large APL patient cohort: a Harmony Alliance study

In this presentation, Maria Teresa Voso, MD, of Tor Vergata University, Rome, Italy, discusses a study using

The Statistics of Life and Death | Survival Analysis

The Statistics of Life and Death | Survival Analysis

Survival analysis

Censoring and Truncation + LOADS OF EXAMPLES - [Survival Analysis 2/8]

Censoring and Truncation + LOADS OF EXAMPLES - [Survival Analysis 2/8]

See all my videos at https://www.zstatistics.com/videos 0:00 Intro | 0:37 CENSORING | 2:46 Example - Right censoring | 5:18 ...